https://charts.traderzeitung.de/phases/US23284F1057
string(1397) "{"isin":"US23284F1057","name":"CytomX Therapeutics Inc","stock_id_xnas":7873653,"stock_id_xnys":null,"generated_at":"2026-08-09 08:04:00","days":[{"date":"2026-08-05","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":3.34,"close_at":"2026-08-05 21:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-08-06","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":3.38,"close_at":"2026-08-06 21:59:00","complete":true,"perf_pct":1.1976},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-08-07","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":3.465,"close_at":"2026-08-07 21:59:00","complete":true,"perf_pct":2.5148},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"
Cytomx Therapeutics Aktie News & Nachrichten
Trading-Room

Cytomx Therapeutics Aktie News & Nachrichten

[WKN: A14158 | Symbol: CTMX]
Realtimekurs
   
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

Cytomx Therapeutics

TOP-5-Kursziele der Analysten am 15.05.25

Scout24 [DE000A12DM80]: JPMorgan nimmt die Aktie auf die "Analyst Focus List" auf und erhöht das Kursziel...

  • ‹
  • 1
  • ›
Cytomx Therapeutics Nachrichtenticker öffnen
MT Newswires 03.06.2026 15:22 Uhr

CytomX Therapeutics erweitert Partnerschaft für Krebstherapie mit Regeneron; Aktien steigen

09:21 AM EDT, 06/03/2026 (MT Newswires) -- CytomX Therapeutics (CTMX) teilte am Mittwoch mit, dass es eine Lizenzvereinbarung mit Regeneron Pharmaceut